| | Symbol | Genename | CARCINOID score | other score |
|---|
| 676_g_at | IFITM1 | interferon induced transmembrane protein 1 (9-27) | -2.2456 | 0.2454 |
|---|
| 33322_i_at | SFN | stratifin | -1.772 | 0.1937 |
|---|
| 675_at | IFITM1 | interferon induced transmembrane protein 1 (9-27) | -1.6363 | 0.1788 |
|---|
| 33323_r_at | SFN | stratifin | -1.4839 | 0.1622 |
|---|
| 37218_at | BTG3 | BTG family, member 3 | -1.2892 | 0.1409 |
|---|
| 33338_at | STAT1 | signal transducer and activator of transcription 1, 91kDa | -1.2441 | 0.136 |
|---|
| AFFX-HUMISGF3A/M97935_3_at | STAT1 | signal transducer and activator of transcription 1, 91kDa | -1.2398 | 0.1355 |
|---|
| 32860_g_at | STAT1 | signal transducer and activator of transcription 1, 91kDa | -1.2274 | 0.1341 |
|---|
| 38589_i_at | PTMA | prothymosin, alpha (gene sequence 28) | -1.2237 | 0.1337 |
|---|
| 38590_r_at | PTMA | prothymosin, alpha (gene sequence 28) | -1.1947 | 0.1306 |
|---|
| 36100_at | VEGF | vascular endothelial growth factor | -1.1834 | 0.1293 |
|---|
| 38708_at | RAN | RAN, member RAS oncogene family | -1.1643 | 0.1272 |
|---|
| 38418_at | CCND1 | cyclin D1 (PRAD1 | -1.1501 | 0.1257 |
|---|
| 33339_g_at | STAT1 | signal transducer and activator of transcription 1, 91kDa | -1.1348 | 0.124 |
|---|
| 1953_at | VEGF | vascular endothelial growth factor | -1.1166 | 0.122 |
|---|
| 577_at | MDK | midkine (neurite growth-promoting factor 2) | -1.1065 | 0.1209 |
|---|
| 38124_at | MDK | midkine (neurite growth-promoting factor 2) | -1.0783 | 0.1178 |
|---|
| 36101_s_at | VEGF | vascular endothelial growth factor | -1.0514 | 0.1149 |
|---|
| 2020_at | CCND1 | cyclin D1 (PRAD1 | -0.9887 | 0.1081 |
|---|
| 2017_s_at | CCND1 | cyclin D1 (PRAD1 | -0.9681 | 0.1058 |
|---|
| 37906_at | LTBP2 | latent transforming growth factor beta binding protein 2 | -0.9116 | 0.0996 |
|---|
| 36909_at | WEE1 | WEE1 homolog (S. pombe) | -0.907 | 0.0991 |
|---|
| 41193_at | DUSP6 | dual specificity phosphatase 6 | -0.8859 | 0.0968 |
|---|
| 36902_at | ARHG | ras homolog gene family, member G (rho G) | -0.8388 | 0.0917 |
|---|
| AFFX-HUMISGF3A/M97935_MA_at | STAT1 | signal transducer and activator of transcription 1, 91kDa | -0.796 | 0.087 |
|---|
| 38810_at | HDAC5 | histone deacetylase 5 | 0.7949 | -0.0869 |
|---|
| 1840_g_at | RAN | RAN, member RAS oncogene family | -0.7891 | 0.0862 |
|---|
| 38326_at | G0S2 | putative lymphocyte G0/G1 switch gene | -0.7688 | 0.084 |
|---|
| 1854_at | MYBL2 | v-myb myeloblastosis viral oncogene homolog (avian)-like 2 | -0.7648 | 0.0836 |
|---|
| 810_at | ARHGEF1 | Rho guanine nucleotide exchange factor (GEF) 1 | -0.7638 | 0.0835 |
|---|
| 33238_at | LCK | lymphocyte-specific protein tyrosine kinase | -0.7622 | 0.0833 |
|---|
| 982_at | MCM5 | MCM5 minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae) | -0.7607 | 0.0831 |
|---|
| 1839_at | RAN | RAN, member RAS oncogene family | -0.757 | 0.0827 |
|---|
| 37483_at | HDAC9 | histone deacetylase 9 | 0.7469 | -0.0816 |
|---|
| 1945_at | CCNB1 | cyclin B1 | -0.7341 | 0.0802 |
|---|
| AFFX-HUMISGF3A/M97935_MB_at | STAT1 | signal transducer and activator of transcription 1, 91kDa | -0.7286 | 0.0796 |
|---|
| 922_at | PPP2R1A | protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform | 0.7255 | -0.0793 |
|---|
| 34736_at | CCNB1 | cyclin B1 | -0.7219 | 0.0789 |
|---|
| 35969_at | MPHOSPH9 | M-phase phosphoprotein 9 | 0.7198 | -0.0787 |
|---|
| 39780_at | PPP3CB | protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) | 0.7157 | -0.0782 |
|---|
| 34822_at | TP53BP2 | tumor protein p53 binding protein, 2 | -0.7155 | 0.0782 |
|---|
| 1796_s_at | BCL3 | B-cell CLL/lymphoma 3 | -0.6989 | 0.0764 |
|---|
| 1884_s_at | PCNA | proliferating cell nuclear antigen | -0.6836 | 0.0747 |
|---|
| 34184_at | APCL | adenomatous polyposis coli like | 0.6765 | -0.0739 |
|---|
| 1616_at | FGF9 | fibroblast growth factor 9 (glia-activating factor) | 0.6658 | -0.0728 |
|---|
| 1830_s_at | TGFB1 | transforming growth factor, beta 1 (Camurati-Engelmann disease) | -0.6591 | 0.072 |
|---|
| AFFX-HUMISGF3A/M97935_5_at | STAT1 | signal transducer and activator of transcription 1, 91kDa | -0.6587 | 0.072 |
|---|
| 2059_s_at | LCK | lymphocyte-specific protein tyrosine kinase | -0.645 | 0.0705 |
|---|
| 1795_g_at | CCND3 | cyclin D3 | -0.6288 | 0.0687 |
|---|
| 32263_at | CCNB2 | cyclin B2 | -0.6212 | 0.0679 |
|---|
| 36650_at | CCND2 | cyclin D2 | 0.6101 | -0.0667 |
|---|
| 1257_s_at | QSCN6 | quiescin Q6 | -0.5981 | 0.0654 |
|---|
| 35970_g_at | MPHOSPH9 | M-phase phosphoprotein 9 | 0.598 | -0.0654 |
|---|
| 37268_at | VEGFB | vascular endothelial growth factor B | 0.5952 | -0.0651 |
|---|
| 39521_at | SLC12A4 | solute carrier family 12 (potassium/chloride transporters), member 4 | -0.5924 | 0.0647 |
|---|
| 35081_at | FGF9 | fibroblast growth factor 9 (glia-activating factor) | 0.5886 | -0.0643 |
|---|
| 39286_at | TOB2 | transducer of ERBB2, 2 | -0.5883 | 0.0643 |
|---|
| 35759_at | CCT2 | chaperonin containing TCP1, subunit 2 (beta) | -0.5851 | 0.064 |
|---|
| 40867_at | PPP2R1A | protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform | 0.5739 | -0.0627 |
|---|
| 38277_at | PPP3CB | protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) | 0.5736 | -0.0627 |
|---|
| 32859_at | STAT1 | signal transducer and activator of transcription 1, 91kDa | -0.5723 | 0.0625 |
|---|
| 1942_s_at | CDK4 | cyclin-dependent kinase 4 | -0.5718 | 0.0625 |
|---|
| 1926_at | VEGFB | vascular endothelial growth factor B | 0.5572 | -0.0609 |
|---|
| 38414_at | CDC20 | CDC20 cell division cycle 20 homolog (S. cerevisiae) | -0.5539 | 0.0605 |
|---|
| 1860_at | TP53BP2 | tumor protein p53 binding protein, 2 | -0.5508 | 0.0602 |
|---|
| 2033_s_at | WEE1 | WEE1 homolog (S. pombe) | -0.5459 | 0.0597 |
|---|
| 1940_at | KRAS2 | v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog | -0.5189 | 0.0567 |
|---|
| 34201_at | DNAJA2 | DnaJ (Hsp40) homolog, subfamily A, member 2 | 0.5147 | -0.0562 |
|---|
| 41700_at | F2R | coagulation factor II (thrombin) receptor | -0.5031 | 0.055 |
|---|
| 39158_at | ATF5 | activating transcription factor 5 | -0.501 | 0.0548 |
|---|
| 924_s_at | PPP2CB | protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform | 0.4999 | -0.0546 |
|---|
| 1347_at | CDC25B | cell division cycle 25B | -0.4923 | 0.0538 |
|---|
| 35249_at | CCNE2 | cyclin E2 | -0.4918 | 0.0537 |
|---|
| 35140_at | CDK8 | cyclin-dependent kinase 8 | 0.4912 | -0.0537 |
|---|
| 1794_at | CCND3 | cyclin D3 | -0.4905 | 0.0536 |
|---|
| 806_at | PLK3 | polo-like kinase 3 (Drosophila) | -0.479 | 0.0523 |
|---|
| 32530_at | YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.4779 | -0.0522 |
|---|
| 1990_g_at | BRCA2 | breast cancer 2, early onset | -0.4778 | 0.0522 |
|---|
| 418_at | MKI67 | antigen identified by monoclonal antibody Ki-67 | -0.4719 | 0.0516 |
|---|
| 1093_at | PPP2R1B | protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform | 0.4686 | -0.0512 |
|---|
| 1094_g_at | PPP2R1B | protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform | 0.4617 | -0.0505 |
|---|
| 409_at | YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.4585 | -0.0501 |
|---|
| 33456_at | MAPRE1 | microtubule-associated protein, RP/EB family, member 1 | -0.4423 | 0.0483 |
|---|
| 1189_at | CDK8 | cyclin-dependent kinase 8 | 0.4391 | -0.048 |
|---|
| 2028_s_at | E2F1 | E2F transcription factor 1 | -0.4268 | 0.0466 |
|---|
| 1824_s_at | PCNA | proliferating cell nuclear antigen | -0.4237 | 0.0463 |
|---|
| 41429_at | PPP2R1B | protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform | 0.4145 | -0.0453 |
|---|
| 2038_g_at | BCL2 | B-cell CLL/lymphoma 2 | -0.4084 | 0.0446 |
|---|
| 35686_s_at | MTCP1 | mature T-cell proliferation 1 | 0.4059 | -0.0444 |
|---|
| 40225_at | GAK | cyclin G associated kinase | -0.4042 | 0.0442 |
|---|
| 37228_at | PLK1 | polo-like kinase 1 (Drosophila) | -0.4024 | 0.044 |
|---|
| 419_at | MKI67 | antigen identified by monoclonal antibody Ki-67 | -0.4018 | 0.0439 |
|---|
| 41060_at | CCNE1 | cyclin E1 | -0.3902 | 0.0426 |
|---|
| 35907_at | CCNF | cyclin F | -0.3893 | 0.0425 |
|---|
| 387_at | CDK9 | cyclin-dependent kinase 9 (CDC2-related kinase) | 0.3852 | -0.0421 |
|---|
| 32304_at | PRKCA | protein kinase C, alpha | -0.3814 | 0.0417 |
|---|
| 1466_s_at | FGF7 | fibroblast growth factor 7 (keratinocyte growth factor) | -0.3772 | 0.0412 |
|---|
| 40708_at | MPHOSPH9 | M-phase phosphoprotein 9 | 0.3753 | -0.041 |
|---|
| 1242_at | ERF | Ets2 repressor factor | 0.3736 | -0.0408 |
|---|
| 159_at | VEGFC | vascular endothelial growth factor C | -0.3713 | 0.0406 |
|---|
| 633_s_at | TFDP2 | transcription factor Dp-2 (E2F dimerization partner 2) | -0.365 | 0.0399 |
|---|
| 40964_at | HK2 | hexokinase 2 | -0.3605 | 0.0394 |
|---|
| 37458_at | CDC45L | CDC45 cell division cycle 45-like (S. cerevisiae) | -0.3591 | 0.0392 |
|---|
| 1767_s_at | TGFB3 | transforming growth factor, beta 3 | -0.3591 | 0.0392 |
|---|
| 34718_at | IGF1R | insulin-like growth factor 1 receptor | -0.3552 | 0.0388 |
|---|
| 1520_s_at | IL1B | interleukin 1, beta | -0.3429 | 0.0375 |
|---|
| 1225_g_at | PCTK1 | PCTAIRE protein kinase 1 | -0.338 | 0.0369 |
|---|
| 38996_at | ERF | Ets2 repressor factor | 0.332 | -0.0363 |
|---|
| 36669_at | FOSB | FBJ murine osteosarcoma viral oncogene homolog B | -0.3234 | 0.0353 |
|---|
| 1266_s_at | LCK | lymphocyte-specific protein tyrosine kinase | 0.3192 | -0.0349 |
|---|
| 39183_at | PCTK1 | PCTAIRE protein kinase 1 | -0.3152 | 0.0344 |
|---|
| 37757_at | TFDP1 | transcription factor Dp-1 | -0.3117 | 0.0341 |
|---|
| 32004_s_at | CDC2L1 | cell division cycle 2-like 1 (PITSLRE proteins) | -0.3066 | 0.0335 |
|---|
| 31864_at | MPHOSPH6 | M-phase phosphoprotein 6 | -0.3043 | 0.0333 |
|---|
| 1768_s_at | CSK | c-src tyrosine kinase | -0.304 | 0.0332 |
|---|
| 32159_at | KRAS2 | v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog | -0.2957 | 0.0323 |
|---|
| 1686_g_at | SPHAR | S-phase response (cyclin-related) | 0.2957 | -0.0323 |
|---|
| 1788_s_at | DUSP4 | dual specificity phosphatase 4 | 0.2885 | -0.0315 |
|---|
| 37468_at | JAK2 | Janus kinase 2 (a protein tyrosine kinase) | -0.2868 | 0.0313 |
|---|
| 160025_at | TGFA | transforming growth factor, alpha | -0.2825 | 0.0309 |
|---|
| 39079_at | ERH | enhancer of rudimentary homolog (Drosophila) | -0.2702 | 0.0295 |
|---|
| 39402_at | IL1B | interleukin 1, beta | -0.2675 | 0.0292 |
|---|
| 33299_at | CDC2L2 | cell division cycle 2-like 2 | -0.2629 | 0.0287 |
|---|
| 1958_at | FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | -0.2606 | 0.0285 |
|---|
| 433_at | MKI67 | antigen identified by monoclonal antibody Ki-67 | 0.2593 | -0.0283 |
|---|
| 617_at | ACPP | acid phosphatase, prostate | -0.2476 | 0.0271 |
|---|
| 39896_at | DHX16 | DEAH (Asp-Glu-Ala-His) box polypeptide 16 | -0.2469 | 0.027 |
|---|
| 37933_at | RBBP6 | retinoblastoma binding protein 6 | -0.243 | 0.0266 |
|---|
| 294_s_at | CDC2L1 | cell division cycle 2-like 1 (PITSLRE proteins) | -0.2415 | 0.0264 |
|---|
| 1224_at | PCTK1 | PCTAIRE protein kinase 1 | -0.2392 | 0.0261 |
|---|
| 996_at | FGF1 | fibroblast growth factor 1 (acidic) | 0.2391 | -0.0261 |
|---|
| 35821_at | HDAC3 | histone deacetylase 3 | 0.2359 | -0.0258 |
|---|
| 1670_at | TFDP1 | transcription factor Dp-1 | -0.2333 | 0.0255 |
|---|
| 1732_at | FGF5 | fibroblast growth factor 5 | 0.2305 | -0.0252 |
|---|
| 32200_at | ACPP | acid phosphatase, prostate | -0.2186 | 0.0239 |
|---|
| 36812_at | BCAR3 | breast cancer anti-estrogen resistance 3 | -0.2181 | 0.0238 |
|---|
| 1207_at | CDK6 | cyclin-dependent kinase 6 | 0.2176 | -0.0238 |
|---|
| 1996_s_at | CCNF | cyclin F | -0.215 | 0.0235 |
|---|
| 33181_at | PPP2CA | protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform | 0.2056 | -0.0225 |
|---|
| 37750_at | UBE2V2 | ubiquitin-conjugating enzyme E2 variant 2 | 0.2012 | -0.022 |
|---|
| 1989_at | BRCA2 | breast cancer 2, early onset | -0.196 | 0.0214 |
|---|
| 37202_at | F2 | coagulation factor II (thrombin) | 0.1917 | -0.021 |
|---|
| 2060_at | BCL2 | B-cell CLL/lymphoma 2 | -0.1913 | 0.0209 |
|---|
| 1685_at | SPHAR | S-phase response (cyclin-related) | 0.1855 | -0.0203 |
|---|
| 36264_at | MATK | megakaryocyte-associated tyrosine kinase | -0.1825 | 0.0199 |
|---|
| 1909_at | BCL2 | B-cell CLL/lymphoma 2 | -0.181 | 0.0198 |
|---|
| 1222_at | PCTK2 | PCTAIRE protein kinase 2 | -0.1807 | 0.0198 |
|---|
| 39873_at | PCTK2 | PCTAIRE protein kinase 2 | -0.1802 | 0.0197 |
|---|
| 1408_at | FGF4 | fibroblast growth factor 4 (heparin secretory transforming protein 1, Kaposi sarcoma oncogene) | 0.1795 | -0.0196 |
|---|
| 1590_s_at | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 0.1765 | -0.0193 |
|---|
| 33556_at | HYPE | Huntingtin interacting protein E | 0.1707 | -0.0187 |
|---|
| 2021_s_at | CCNE1 | cyclin E1 | -0.1696 | 0.0185 |
|---|
| 33975_at | BTC | betacellulin | -0.1653 | 0.0181 |
|---|
| 41445_at | TGFB1 | transforming growth factor, beta 1 (Camurati-Engelmann disease) | 0.1641 | -0.0179 |
|---|
| 511_s_at | FRK | fyn-related kinase | -0.1631 | 0.0178 |
|---|
| 1923_at | CCNC | cyclin C | -0.1601 | 0.0175 |
|---|
| 38158_at | ESPL1 | extra spindle poles like 1 (S. cerevisiae) | 0.1591 | -0.0174 |
|---|
| 33536_at | PRKG2 | protein kinase, cGMP-dependent, type II | 0.1535 | -0.0168 |
|---|
| 1335_at | IGF1R | insulin-like growth factor 1 receptor | -0.1495 | 0.0163 |
|---|
| 35687_at | MTCP1 | mature T-cell proliferation 1 | -0.1493 | 0.0163 |
|---|
| 39208_i_at | PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | -0.149 | 0.0163 |
|---|
| 1312_at | PSMD8 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 | -0.1477 | 0.0161 |
|---|
| 1279_s_at | CDK3 | cyclin-dependent kinase 3 | 0.1433 | -0.0157 |
|---|
| 35023_at | FRK | fyn-related kinase | -0.1298 | 0.0142 |
|---|
| 33205_at | SUPT3H | suppressor of Ty 3 homolog (S. cerevisiae) | 0.1298 | -0.0142 |
|---|
| 1000_at | MAPK3 | mitogen-activated protein kinase 3 | 0.1296 | -0.0142 |
|---|
| 37107_at | PPM1D | protein phosphatase 1D magnesium-dependent, delta isoform | 0.1269 | -0.0139 |
|---|
| 1322_at | E2F1 | E2F transcription factor 1 | 0.1211 | -0.0132 |
|---|
| 35145_at | MNT | MAX binding protein | 0.1191 | -0.013 |
|---|
| 795_s_at | CDKL1 | cyclin-dependent kinase-like 1 (CDC2-related kinase) | -0.1184 | 0.0129 |
|---|
| 35701_at | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 0.118 | -0.0129 |
|---|
| 34741_at | TFDP2 | transcription factor Dp-2 (E2F dimerization partner 2) | -0.117 | 0.0128 |
|---|
| 1934_s_at | VEGFC | vascular endothelial growth factor C | -0.1166 | 0.0127 |
|---|
| 33826_at | CIZ1 | CDKN1A interacting zinc finger protein 1 | 0.1108 | -0.0121 |
|---|
| 1735_g_at | TGFB3 | transforming growth factor, beta 3 | -0.1081 | 0.0118 |
|---|
| 41546_at | CDK6 | cyclin-dependent kinase 6 | -0.1044 | 0.0114 |
|---|
| 796_i_at | CDKL1 | cyclin-dependent kinase-like 1 (CDC2-related kinase) | -0.1035 | 0.0113 |
|---|
| 267_at | FRAP1 | FK506 binding protein 12-rapamycin associated protein 1 | -0.1027 | 0.0112 |
|---|
| 1744_at | CCND1 | cyclin D1 (PRAD1 | 0.1011 | -0.011 |
|---|
| 37574_at | NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.1004 | -0.011 |
|---|
| 1910_s_at | BCL2 | B-cell CLL/lymphoma 2 | -0.0985 | 0.0108 |
|---|
| 1503_at | BRCA2 | breast cancer 2, early onset | -0.0985 | 0.0108 |
|---|
| 31699_at | PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | -0.098 | 0.0107 |
|---|
| 1174_at | MOS | v-mos Moloney murine sarcoma viral oncogene homolog | -0.0969 | 0.0106 |
|---|
| 40566_at | PRKCA | protein kinase C, alpha | 0.0951 | -0.0104 |
|---|
| 40575_at | DLG5 | discs, large homolog 5 (Drosophila) | -0.0921 | 0.0101 |
|---|
| 40226_at | GAK | cyclin G associated kinase | 0.0918 | -0.01 |
|---|
| 2013_at | TFDP2 | transcription factor Dp-2 (E2F dimerization partner 2) | -0.0914 | 0.01 |
|---|
| 38625_g_at | SLC12A4 | solute carrier family 12 (potassium/chloride transporters), member 4 | -0.0885 | 0.0097 |
|---|
| 1539_at | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | -0.0883 | 0.0097 |
|---|
| 38720_at | CCT7 | chaperonin containing TCP1, subunit 7 (eta) | -0.0871 | 0.0095 |
|---|
| 37758_s_at | TFDP1 | transcription factor Dp-1 | -0.0867 | 0.0095 |
|---|
| 2079_s_at | IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.0821 | -0.009 |
|---|
| 1730_s_at | FGF4 | fibroblast growth factor 4 (heparin secretory transforming protein 1, Kaposi sarcoma oncogene) | -0.0811 | 0.0089 |
|---|
| 1634_s_at | TGFB1 | transforming growth factor, beta 1 (Camurati-Engelmann disease) | 0.0766 | -0.0084 |
|---|
| 32833_at | CLK1 | CDC-like kinase 1 | 0.0697 | -0.0076 |
|---|
| 1573_at | PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.0657 | -0.0072 |
|---|
| 1941_at | SKP2 | S-phase kinase-associated protein 2 (p45) | 0.0652 | -0.0071 |
|---|
| 1525_s_at | FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.0649 | -0.0071 |
|---|
| 1664_at | IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.0645 | -0.0071 |
|---|
| 32568_at | BTG3 | BTG family, member 3 | -0.0639 | 0.007 |
|---|
| 1076_at | IL1A | interleukin 1, alpha | 0.0638 | -0.007 |
|---|
| 41545_at | CDK6 | cyclin-dependent kinase 6 | -0.0605 | 0.0066 |
|---|
| 38265_at | RBBP6 | retinoblastoma binding protein 6 | 0.0597 | -0.0065 |
|---|
| 1855_at | FGF3 | fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog) | -0.0584 | 0.0064 |
|---|
| 37789_at | TADA2L | transcriptional adaptor 2 (ADA2 homolog, yeast)-like | -0.0575 | 0.0063 |
|---|
| 1925_at | CCNF | cyclin F | -0.0564 | 0.0062 |
|---|
| 1380_at | FGF7 | fibroblast growth factor 7 (keratinocyte growth factor) | 0.055 | -0.006 |
|---|
| 36782_s_at | IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.0548 | -0.006 |
|---|
| 35749_at | TADA3L | transcriptional adaptor 3 (NGG1 homolog, yeast)-like | -0.0537 | 0.0059 |
|---|
| 1437_at | PRKCA | protein kinase C, alpha | 0.053 | -0.0058 |
|---|
| 1702_at | IL2RA | interleukin 2 receptor, alpha | 0.0495 | -0.0054 |
|---|
| 39251_at | CCNC | cyclin C | -0.0486 | 0.0053 |
|---|
| 40139_at | FRAP1 | FK506 binding protein 12-rapamycin associated protein 1 | -0.0486 | 0.0053 |
|---|
| 40707_at | MPHOSPH9 | M-phase phosphoprotein 9 | 0.0475 | -0.0052 |
|---|
| 237_s_at | PPP2CA | protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform | 0.0458 | -0.005 |
|---|
| 35836_at | NUDC | nuclear distribution gene C homolog (A. nidulans) | -0.0434 | 0.0047 |
|---|
| 39449_at | SKP2 | S-phase kinase-associated protein 2 (p45) | -0.0425 | 0.0046 |
|---|
| 35980_at | PLCB1 | phospholipase C, beta 1 (phosphoinositide-specific) | -0.0416 | 0.0045 |
|---|
| 378_s_at | GML | GPI anchored molecule like protein | -0.0414 | 0.0045 |
|---|
| 35703_at | PDGFA | platelet-derived growth factor alpha polypeptide | -0.0406 | 0.0044 |
|---|
| 793_at | PGF | placental growth factor, vascular endothelial growth factor-related protein | -0.0378 | 0.0041 |
|---|
| 1983_at | CCND2 | cyclin D2 | -0.0339 | 0.0037 |
|---|
| 36073_at | NDN | necdin homolog (mouse) | -0.0324 | 0.0035 |
|---|
| 38624_at | SLC12A4 | solute carrier family 12 (potassium/chloride transporters), member 4 | 0.0311 | -0.0034 |
|---|
| 1526_i_at | FGF8 | fibroblast growth factor 8 (androgen-induced) | -0.0304 | 0.0033 |
|---|
| 971_s_at | TGFB2 | transforming growth factor, beta 2 | -0.0249 | 0.0027 |
|---|
| 35688_g_at | MTCP1 | mature T-cell proliferation 1 | 0.0225 | -0.0025 |
|---|
| 292_s_at | CLK1 | CDC-like kinase 1 | 0.0219 | -0.0024 |
|---|
| 32452_at | CDK3 | cyclin-dependent kinase 3 | -0.0215 | 0.0024 |
|---|
| 39209_r_at | PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | -0.0193 | 0.0021 |
|---|
| 32126_at | FGF7 | fibroblast growth factor 7 (keratinocyte growth factor) | -0.0175 | 0.0019 |
|---|
| 1109_s_at | PDGFA | platelet-derived growth factor alpha polypeptide | 0.017 | -0.0019 |
|---|
| 32584_at | PSMD8 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 | -0.0124 | 0.0014 |
|---|
| 1734_at | TGFB3 | transforming growth factor, beta 3 | 0.0097 | -0.0011 |
|---|
| 40680_at | SPIN2 | spindlin family, member 2 | 0.0079 | -9e-04 |
|---|
| 34476_r_at | EREG | epiregulin | -0.0076 | 8e-04 |
|---|
| 1163_at | PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.0056 | -6e-04 |
|---|
| 1262_s_at | TGFB2 | transforming growth factor, beta 2 | -0.0052 | 6e-04 |
|---|
| 1591_s_at | IGF2 | insulin-like growth factor 2 (somatomedin A) | -0.0017 | 2e-04 |
|---|
| 1847_s_at | BCL2 | B-cell CLL/lymphoma 2 | 0.0015 | -2e-04 |
|---|
| 31928_at | FGF6 | fibroblast growth factor 6 | 3e-04 | 0 |
|---|